Work

A pilot trial of hu14.18-IL2 in patients with completely resectable recurrent stage III or stage IV melanoma.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.9044

Authors: Mark R. Albertini, Erik Ranheim, Jacquelyn A Hank, Cindy Zuleger, Thomas McFarland, Jennifer Collins, Erin Clements, Sharon M. Weber, Tracey Weigel, Heather B. Neuman, Gregory K Hartig, David Mahvi, MaryBeth Henry, Jacek Gan, Richard Yang, KyungMann Kim, Stephen Gillies, Paul M. Sondel

Institutions: University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center, Maine Medical Center, Northwestern University

Language: English

Topic: Cutaneous Melanoma Detection and Management

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2604085451

Cites:

Cited by: 3

Related to: 10